{
  "patientId": "22334",
  "demographics": {
    "name": "David Garcia",
    "dob": "1959-04-11",
    "gender": "Male",
    "address": "67 Oak Circle, Anytown, USA",
    "phone": "555-2233",
    "insurance": "Cigna",
    "referringPhysician": "Dr. Mark Johnson (Medical Oncology)",
    "emergencyContact": "Not specified in record"
  },
  "diagnosis": {
    "primary": "Pancreatic Adenocarcinoma",
    "location": "Head of Pancreas",
    "grade": "Moderately Differentiated (Grade 2)",
    "datePathologicDiagnosis": "02/01/2025 (EUS-guided Biopsy)",
    "tumorSize": "~3 cm",
    "vascularInvolvement": "Abuts SMV (<180 degrees), no SMA involvement.",
    "clinicalStage": "Borderline Resectable",
    "symptomsAtPresentation": "Painless jaundice, dark urine, mild back pain, weight loss.",
    "pathologyFindings": [
      "EUS-guided biopsy of pancreatic head mass confirms Adenocarcinoma, moderately differentiated.",
      "Sampled peripancreatic lymph node negative for malignant cells."
    ],
    "priorProcedures": "ERCP with biliary stent placement (02/05/2025)",
    "baselineStatus": "ECOG 1",
    "priorTreatmentSummary": "Completed 4 cycles FOLFIRINOX (induction)"
  },
  "treatmentPlan": {
    "radOnc": "Dr. Robert Evans",
    "medOnc": "Dr. Mark Johnson",
    "surgOnc": "Dr. Laura Chen",
    "treatmentSite": "Pancreas Head",
    "intent": "Neoadjuvant (Pre-operative)",
    "modality": "External Beam Radiation Therapy (EBRT) with concurrent Chemotherapy (following induction chemo)",
    "rtRxDetails": "50.4 Gy in 28 fractions (1.8 Gy/fx)",
    "targetVolumeSummary": "PTV encompassing pancreatic head tumor + margin, potentially including draining nodal regions.",
    "techniqueSummary": "IMRT",
    "concurrentChemo": "Capecitabine",
    "detailedConcurrentChemo": "Capecitabine PO BID during radiation (Managed by Dr. Johnson)",
    "medications": [
      "Ondansetron PRN Nausea",
      "Loperamide PRN Diarrhea",
      "Pancreatic Enzymes (e.g., Creon) if needed for insufficiency"
    ],
    "therapistAlerts": [
        "High risk for nausea and GI side effects.",
        "Assess hydration and nutrition status daily.",
        "Patient taking oral chemotherapy (Capecitabine); reinforce compliance instructions."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "05/20/2025",
      "setupInstructions": "Supine in BodyFix or VacLok bag, abdominal compression may be used. 4D-CT simulation to manage respiratory motion. SAD setup.",
      "immobilization": "BodyFix or VacLok bag, abdominal compression.",
      "referenceMarks": "3-point tattoos at isocenter projections (AP and bilateral laterals).",
      "setupImages": [
        { "type": "AP", "url": "https://placehold.co/250x200/EEE/31343C?text=AP+Setup+Photo" },
        { "type": "Lateral", "url": "https://placehold.co/250x200/EEE/31343C?text=Lateral+Setup+Photo" }
      ],
      "scanner": "Siemens Somatom go.Up",
      "sliceThickness": "2.5 mm",
      "contrastUsed": "IV Contrast and oral contrast (for bowel delineation) likely used.",
      "ctNotes": "4D-CT acquired with immobilization/compression. Motion assessed. Data acquired for IMRT planning. Fused with diagnostic CT."
    },
    "dosimetry": {
      "planId": "DG22334_Panc",
      "planStatus": "Final - Approved by Dr. Robert Evans",
      "rx": "50.4 Gy / 28 fx",
      "technique": "IMRT",
      "energy": "6MV",
      "numberOfFieldsOrArcs": 7,
      "gantryAngles": "Multiple Static",
      "collAngles": "Variable",
      "couchAngles": "0",
      "isoCoords": "L0.0, L+8.0, V-5.0",
      "tps": "Eclipse",
      "algorithm": "AcurosXB",
      "hetero": "Yes",
      "norm": "PTV Mean 95%",
      "constraints": "Kidney Mean < 18 Gy; Stomach Max < 54 Gy; Bowel Max < 54 Gy",
      "planNotes": "Neoadjuvant IMRT for borderline resectable pancreatic cancer.",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "CBCT",
        "alignment": "Soft tissue match to GTV/pancreas head."
      },
      "qaChecks": [
        { "date": "2025-05-23", "type": "Initial Chart Check", "by": "Physics Staff" },
        { "date": "2025-05-23", "type": "Patient Specific QA", "by": "Physics Staff", "result": "Pass" }
      ],
      "fieldDetails": [
        { "fieldName": "Field 1", "fieldSize": "12x14 cm", "gantryAngle": "0", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 62, "ssd": "88.5 cm"},
        { "fieldName": "Field 2", "fieldSize": "12x14 cm", "gantryAngle": "51", "collimatorAngle": "30", "couchAngle": "0", "energy": "6MV", "monitorUnits": 78, "ssd": "89.0 cm"},
        { "fieldName": "Field 3", "fieldSize": "12x14 cm", "gantryAngle": "102", "collimatorAngle": "330", "couchAngle": "0", "energy": "6MV", "monitorUnits": 71, "ssd": "90.0 cm"},
        { "fieldName": "Field 4", "fieldSize": "12x14 cm", "gantryAngle": "153", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 66, "ssd": "91.5 cm"},
        { "fieldName": "Field 5", "fieldSize": "12x14 cm", "gantryAngle": "204", "collimatorAngle": "30", "couchAngle": "0", "energy": "6MV", "monitorUnits": 72, "ssd": "90.5 cm"},
        { "fieldName": "Field 6", "fieldSize": "12x14 cm", "gantryAngle": "255", "collimatorAngle": "330", "couchAngle": "0", "energy": "6MV", "monitorUnits": 77, "ssd": "89.5 cm"},
        { "fieldName": "Field 7", "fieldSize": "12x14 cm", "gantryAngle": "306", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 61, "ssd": "88.0 cm"}
      ]
    },
    "treatmentDelivery": {
      "fractions": []
    }
  },
  "imagingAndReports": [
    { "date": "01/20/2025", "type": "CT Abdomen/Pelvis w/ Contrast (Pancreas Protocol)", "summary": "3cm hypodense mass head of pancreas, abutting SMV. Dilated biliary ducts.", "reportDetails": {} },
    { "date": "01/28/2025", "type": "CT Chest", "summary": "No evidence of metastatic disease.", "reportDetails": {} },
    {
      "date": "02/01/2025",
      "type": "EUS Biopsy Report",
      "summary": "Adenocarcinoma consistent with pancreatic primary.",
      "reportDetails": {
        "accessionNumber": "S25-23456",
        "specimenSource": "EUS-guided Fine Needle Aspiration (FNA) and Biopsy: 1) Pancreatic head mass, 2) Peripancreatic lymph node (Station 8a).",
        "finalDiagnosis": "1. PANCREATIC HEAD MASS, FNA AND BIOPSY: ADENOCARCINOMA, MODERATELY DIFFERENTIATED (GRADE 2).\n2. PERIPANCREATIC LYMPH NODE (STATION 8A), FNA: NEGATIVE FOR MALIGNANT CELLS.",
        "microscopicDescription": "The specimen from the pancreatic mass consists of core biopsy fragments and smears showing infiltrating glandular structures lined by atypical epithelial cells with enlarged, pleomorphic nuclei and prominent nucleoli. Mitotic figures are identified. The specimen from the lymph node consists of smears showing a population of benign, reactive lymphoid elements only. No malignant cells are seen.",
        "comment": "The findings are diagnostic of adenocarcinoma of the pancreas. The sampled peripancreatic lymph node shows no evidence of metastasis, which is important for staging and surgical planning."
      }
    },
    { "date": "05/15/2025", "type": "CT Abdomen/Pelvis w/ Contrast (Pancreas Protocol)", "summary": "Interval decrease in tumor size to 2.5cm. Continued abutment of SMV. Stable disease/slight response.", "reportDetails": {} }
  ],
  "dicomImages": [],
  "labResults": [],
  "progressNotes": [],
  "patientEducation": {},
  "scheduling": [],
  "cptCharges": [],
  "diagnosisSearch": "Pancreatic Cancer"
}
